US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

33.27

0.0000

Volume:269

Turnover:8.90K

Market Cap:6.65M

PE:- -

High:33.27

Open:33.27

Low:33.27

Close:33.27

52wk High:43.01

52wk Low:26.17

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.72

T/O Rate:0.13%

Dividend:0.32

Dividend Rate:0.96%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says

MT Newswires Live

Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares

How to Build an OPC in Hebei

Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBRN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":33.265,"timestamp":1790866882958,"preClose":33.265,"halted":0,"volume":269,"delay":0,"changeRate":0,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"10-01 11:33:15 EDT","open":33.265,"high":33.265,"low":33.265,"amount":8896.65314,"amplitude":0,"askPrice":33.09,"askSize":400,"bidPrice":32.85,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.265,"sharesOutstanding":150000,"nav":33.20084,"aum":6640168,"dividendRate":0.009581,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.45,"preClose":33.265,"latestTime":"16:10 EDT","volume":6,"amount":199.56,"timestamp":1790799005063,"change":0.185,"changeRate":0.005561,"amplitude":0},"volumeRatio":0.716504,"impliedVol":0.0726,"impliedVolPercentile":0.3147},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.716504,"shares":200000,"dividePrice":0.3187,"high":33.265,"amplitude":0,"preClose":33.265,"low":33.265,"week52Low":26.1718,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":33.265,"eps":0,"divideRate":0.009581,"volume":269,"delay":0,"ttmEps":0,"open":33.265,"prevYearClose":32.3193,"prevWeekClose":33.3342,"prevMonthClose":33.265,"prevQuarterClose":33.265,"fiveDayClose":33.525,"twentyDayClose":39.4587,"sixtyDayClose":39.9088},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672876399","title":"Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672876399","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672876399?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:02","pubTimestamp":1790866926,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals'  safety data has raised investor concerns about a potential Food and Drug Administration warning for azetukalner, or AZK, though approval appears largely unaffected, RBC Capital Markets said Thursday in a report.Recent updates from the company's psychiatry program have raised investor concerns that neuropsychological adverse events may lead the FDA to add a warning, potentially even a boxed warning, to AZK's focal-onset seizures label, RBC said. Investors are also concerned that this could hurt AZK's commercial uptake and weigh on the stock, the report said.Based on historical precedent, AZK's data to date, and recent FDA feedback, RBC said it doesn't believe AZK is likely to receive a molecule-specific boxed warning, and that approval or commercial uptake isn't facing major risk.\"We continue to see $1.5 billion focal-onset seizures potential, justifying a higher valuation, and while acknowledging it may take time for investors to be reassured, view recent weakne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XENE","IBRN","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672813750","title":"Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672813750","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672813750?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:20","pubTimestamp":1790860804,"startTime":"0","endTime":"0","summary":"Xenon Pharma CEO Ian Mortimer acquires $1,121,400 in common sharesXenon Pharmaceuticals President and CEO Ian Mortimer bought 30,000 common shares at USD 37.38 each.Directly held stake rose to 49,923 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLr2q46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","XENE","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157930495","title":"How to Build an OPC in Hebei","url":"https://stock-news.laohu8.com/highlight/detail?id=1157930495","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157930495?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:01","pubTimestamp":1790856101,"startTime":"0","endTime":"0","summary":"Entrepreneurship is becoming increasingly \"light.\" No need to gather partners, no need to build complex teams—one person or a few people, with the help of AI tools, can open a legitimate limited...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","MNTL","ARTY","AIPO","AGIX","IBRN","CHAT","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521211","title":"Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:01","pubTimestamp":1790683277,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics to present Phase 3 CAPTIVATE interim analysis of claseprubart in CIDP at 2026 AANEM meetingDianthus Therapeutics flagged new clinical updates for its complement inhibitor clasepr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL62W9hR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","DNTH","BCDF","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","BK4139","IBRN","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BQXX3C00.GBP","SG9999014039.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBRN\",params:#limit:6,delay:false,,,undefined,":[]}}